ERRγ, a Novel Biomarker, Associates with Pathoglycemia of Endometrial Cancer to Predict Myometrial Invasion

Table 2

Clinical data comparison of EC patients with different myometrial invasion depth groups.

Variable	n	≥1/2	n	<1/2	value
Age (years)	141	56.96 ± 9.32	384	52.44 ± 8.08	<0.001
BMI (kg/m^2)	112	24.56 ± 3.33	299	24.50 ± 3.46	0.875
FBG (mmol/L)	141	5.82 ± 1.59	383	5.34 ± 1.07	0.001
TG (mmol/L)	140	1.57 ± 1.14	383	1.57 ± 0.95	0.960
TC (mmol/L)	140	4.95 ± 1.09	382	4.98 ± 0.92	0.772
HDL (mmol/L)	116	1.41 ± 0.27	345	1.41 ± 0.38	0.969
LDL (mmol/L)	86	2.96 ± 0.98	259	2.87 ± 0.74	0.384
CA125 (U/mL)	139	96.90 ± 246.89	369	36.91 ± 173.12	0.009
CA15-3 (U/mL)	132	14.69 ± 20.36	362	11.07 ± 11.36	0.055
CA19-9 (U/mL)	128	207.43 ± 1020.83	325	71.40 ± 670.46	0.165
SCC (ug/L)	111	1.49 ± 1.29	290	1.25 ± 1.07	0.065
AFP (ng/mL)	130	3.47 ± 7.64	348	2.72 ± 1.41	0.268
CEA (ng/mL)	130	2.16 ± 1.46	354	2.05 ± 1.91	0.554

Notes: BMI: body mass index; FBG: fasting blood glucose; TG: triglyceride; TC: total cholesterol; HDL: high-density lipoprotein; LDL: low-density lipoprotein. ; .